Loading menubar.....

Difference between revisions of "Team:Tuebingen/einweiterer"

Line 1: Line 1:
<!DOCTYPE html>
 
 
<html lang="en" dir="ltr" class="client-nojs" xmlns="http://www.w3.org/1999/html">
 
<html lang="en" dir="ltr" class="client-nojs" xmlns="http://www.w3.org/1999/html">
  
Line 10,705: Line 10,704:
 
<div class="header">
 
<div class="header">
 
   <div class="info">
 
   <div class="info">
     <h1 style="font-family: 'Righteous', cursive; font-weight: normal; color:#2ecc71;">GLP.exe</h1>
+
     <h1 style="font-family: 'Righteous', cursive; font-weight: normal; color:#2ecc71;">Nissle</h1>
 
   </div>
 
   </div>
 
</div>
 
</div>
Line 10,723: Line 10,722:
 
         <div id="image-popups">
 
         <div id="image-popups">
  
         <h2 style="font-family:'Righteous'; color:#2ecc71;">Abstract</h2>
+
         <h2 style="font-family:'Righteous'; color:#2ecc71;">Introduction</h2>
 
         <div class="row">
 
         <div class="row">
 
             <div class="col-12">
 
             <div class="col-12">
 
                 <p>
 
                 <p>
                     Diabetes Mellitus is one of the main diseases causing premature death worldwide [16].
+
                     Escherichia coli Nissle 1917 (EcN) is probably the most intensively investigated bacterial strain
                     In 2014, 422 Million adults were diagnosed with Diabetes Mellitus worldwide [1], an
+
                     today[1]. Despite the fact that the EcN strain is widely used as a probiotic, a lot of questions
                    alarmingly high number. This inspired us to look into alternative treatment strategies for
+
                     remain. That is why we decided to dive deep into the characterization of EcN. Our goal was to find
                    Type 2 Diabetes Mellitus, as it marks the largest group of Diabetes patients.
+
                     out more about EcN itself and to provide crucial information in order to include EcN as platform
                    There already is a variety of treatment options, however they all require active participation
+
                     organism for other iGEM Teams and researchers.
                    of the patients and compliance to their individual therapy schemes. As compliance and persistence
+
                    are key factors for therapeutic success, we, the iGEM Team Tübingen, want to revolutionize
+
                    the treatment and its administration with the use of Synthetic Biology. We therefore developed
+
                    GLP.exe a probiotic on the basis of Escherichia coli Nissle which secretes Exenatid, an incretin anologon,
+
                     in response to glucose. To ensure its safe use as a GMO we invented a CRISPR/Cas3-based kill-switch
+
                    integrated into our probiotic. This kill-switch is regulated by environmental factors and prevents
+
                    the release and spread of our GMO into the environment. Our probiotic allows for a single-time
+
                     application as it independently synthesises the drug when it is needed. To deepen our understanding
+
                    of our probiotic strain we also worked on characterising E.coli Nissle via different means such as
+
                    RNA-Seq and metabolic modelling. This characterisation will be benefitial for the iGEM and general
+
                    scientific community in future projects. The use of GMOs, especially in the medical field, is a
+
                    delicate topic and great efforts were made during our project to spread awareness and to educate
+
                     the public about synthetic biology, GMOs and Diabetes.
+
                </p>
+
                <p>
+
                    In order to design an impactful project for this year’s iGEM season, we deemed it important to
+
                    precisely understand and define the problem we wanted to work on.
+
                </p>
+
                <p>
+
                    Through extensive research into the factors impeding phage therapy, we identified the production
+
                    process to be one of the most striking problems. In particular, the current methods are inefficient,
+
                    lead to high impurities and contamination, require the cultivation of human pathogens in large
+
                    quantities and causes regulatory problems due to imprecise manufacturing standards and a lack of
+
                    adequate quality controls.
+
 
                 </p>
 
                 </p>
 
             </div>
 
             </div>
 +
        </div>
  
             <h2 style="font-family:'Righteous'; color:#2ecc71;">Project Inspiration</h2>
+
             <h2 style="font-family:'Righteous'; color:#2ecc71;">Growth Curves</h2>
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
 
                     <p>
 
                     <p>
                         When committing to iGEM, we decided we firstly wanted to design a project which uses a new
+
                         The first step in the characterization of a bacterium are growth curves on different media and
                        system of the field of synthetic biology, and secondly to make an impact with a product,
+
                         under different conditions. We chose to perform half of our experiments under aerobic and the
                         which can actually be of use to the society. So when Dr. Pengfei Xia, one of our advisors
+
                         other half under anaerobic conditions. Under aerobic conditions, as a control we let EcN grow in
                        proposed to design a new kill-switch system for bacteria, based on the Type I CRISPR system
+
                         LB medium at 37°C and pH7. We changed the temperature to 25°C, 8°C, 4°C and 0°C, showing that
                         CRISPR/Cas3, we were determined to not only implement the system, but also find a way of making
+
                         EcN growth is inhibited at 8°C, the temperature often used for cold shock.
                         it a useful, universally applicable, tool. As Diabetes Mellitus Type 2 becomes more and more
+
                         epidemic, with some of our team members relatives also suffering from it, and a problem for
+
                        society and the healthcare system, we decided to focus our project on this disease.
+
 
                     </p>
 
                     </p>
  
                     <p>
+
                     <figure>
                         We thought about changes in therapy, which would make it easier to comply with the therapy
+
                         <a style="font-size: small"
                        scheme and identified issues like the required daily injections and multiple drugs, which need
+
                          href="https://2019.igem.org/wiki/images/b/b5/T--Tuebingen--pH7-diff-Temp-white.png"
                        to be taken at certain times during the day. Overall, we came to the conclusion that a probiotic
+
                          data-effect="mfp-zoom-out"
                        bacterium synthesising a drug when required, and therefore lifting the burden of application
+
                          title="Some title">
                         from the patient, would be our way to go. On top of that, we realized that in 2017 Team AQA_Unesp
+
                            <img src="https://2019.igem.org/wiki/images/b/b5/T--Tuebingen--pH7-diff-Temp-white.png"
                        had already tried to target Type 1 Diabetes Mellitus with a probiotic, hence we felt that the
+
                                class="figure-img img-fluid rounded"
                        viability of the idea was supported by this [7]. Additionally, this approach would allow us to
+
                                alt="A generic square placeholder"></a>
                        not only use our bacterium with the CRISPR/Cas3 system as biofactory, but also make it the
+
                         <figcaption style="font-size: small; color: #F4F0DE">Fig. 1: EcN growth in LB medium at pH7. All cultures were
                        therapeutic agent which is applied, making the biosafety function of CRISPR/Cas3, not only a
+
                            inoculated with an overnight culture and grown for 120 minutes at 37°C. Next, temperature was
                        tool, but also a requirement for safe application.</p>
+
                            changed to 0°C, 4°C, 8°C and 25°C, while one control was kept at 37°C.
 +
                            Shown are mean values of triplicates.</figcaption>
 +
                    </figure>
  
 
                     <p>
 
                     <p>
                         The idea of using GMOs as probiotics, is generally of great interest for chronic diseases.
+
                         Moreover, we evaluated the growth in the pH range from pH6 to pH1, since in our application EcN
                        Therefore, we want to use the application in Type 2 Diabetes Mellitus as an example of the
+
                         will have to pass the acidity of the stomach. Here, at pH4 we discovered an interesting recovery
                         strengths and limitations of such a system, and use our public involvement to gather the society’s
+
                         of EcN growth after three hours.
                        perception and opinion of such a therapeutic strategy. Overall, we consider our project to be
+
                        an important trial for the use of synthetic biology in long-term therapy, during which the patient
+
                         is not restricted to stay within a facility, but can live normally and without financial or other
+
                        burdens of the disease. By designing a safe system which will prohibit the survival of GMOs within
+
                        the environment, our project aims at enabling the use of probiotics in modern therapy.
+
 
                     </p>
 
                     </p>
                </div>
 
            </div>
 
  
            <h2 class="tocitem" style="text-align: left;font-family:'Righteous'; color:#2ecc71;">Glucose-dependent Incretin secretion</h2>
 
              <div class="row align-items-center">
 
                <div class="col-12 col-md-5">
 
 
                     <figure>
 
                     <figure>
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/4/45/T--Tuebingen--Glucose-dep-Incretin-system.png"
+
                           href="https://2019.igem.org/wiki/images/c/cf/T--Tuebingen--37-diff-pH-white.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/4/45/T--Tuebingen--Glucose-dep-Incretin-system.png"
+
                             <img src="https://2019.igem.org/wiki/images/c/cf/T--Tuebingen--37-diff-pH-white.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="Placeholder"></a>
+
                                 alt="A generic square placeholder"></a>
 +
                        <figcaption style="font-size: small; color: #F4F0DE">Fig. 2: EcN growth curve in LB at 37°C under
 +
                            different pH levels. Until 120min all cultures inoculated from one overnight culture grew at pH7.
 +
                            Then, media was changed to the respective pH and cultures were grown for 3 hours. pH5 and pH6
 +
                            grew as usual, pH1,2,3 did not grow at all, while pH4 started to grow after 3 hours. Thus,
 +
                            media was changed again after 3 hours to pH7. pH6 and pH5 grew as usual, pH1,2,3 did not
 +
                            recover. Cultures grown in pH4 recovered and grew as usual. Shown are values of one culture
 +
                            for each pH.</figcaption>
 
                     </figure>
 
                     </figure>
        </div>
 
    <div class="col-12 col-md-7">
 
        <p>
 
            Our probiotic secretes Exenatid-4, an Incretin mimetic, in response to glucose availability in
 
                        the human gut. The system works via the carbon catabolite repression system which will initiate
 
                        the transcription of tetR. Upstream of our Exenatid-4 is a TetR repressible promoter, which ensures
 
                        that Exenatid-4 is only transcribed in the presence of glucose. Furthermore, our Exenatid-4 is
 
                        coupled to an N-terminal secretion tag and a C-terminal cell penetrating peptide (CPP), which
 
                        together ensure the secretion and uptake of our drug increasing its bioavailability. Due to the
 
                        immense variety of CPPs and the lack of quantitative information about their efficiency, we also
 
                        developed a <a href="https://2019.igem.org/Team:Tuebingen/Software" onclick='window.open("https://www.google.com","_self");'>predictive software tool</a>
 
                        to allow for educated decisions on the design of CPPs.[LINK ZU INCRETIN SEITE]
 
        </p>
 
    </div>
 
</div>
 
            </div>
 
  
 
+
                    <figure>
            <h2 style="font-family:'Righteous';">CRISPR/Cas3 kill-switch</h2>
+
                        <a style="font-size: small"
            <div class="row">
+
                          href="https://2019.igem.org/wiki/images/b/b8/T--Tuebingen--pH4-3x-37-white.png"
                <div class="col-12">
+
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/b/b8/T--Tuebingen--pH4-3x-37-white.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="A generic square placeholder"></a>
 +
                        <figcaption style="font-size: small; color: #F4F0DE">Fig. 3: EcN growth in LB at 37°C with pH
 +
                            changed from pH7 to pH4 after two hours of growth. After 150 minutes within pH4,
 +
                            EcN started to grow comparable to pH7 cultures. Shown are the three cultures inoculated
 +
                            from the same overnight culture of EcN.</figcaption>
 +
                    </figure>
 
                     <p>
 
                     <p>
                         The implemented and newly developed CRISPR/Cas3 kill-switch allows for the safe use of our probiotic.
+
                         To look into inflammatory stress, we subjected EcN to up to 100µM hydrogen peroxide [2] and showed
                        Once the kill-switch is activated the Cas3 nuclease degrades the bacterial nucleic acid and therefore
+
                         that the growth is not  substantially influenced by it.
                        prevents the spread of GMOs into the environment. The kill switch is regulated by three environmental
+
                        factors which are common in a healthy humans intestine: 37°C, availability of fatty acids in form of
+
                        Acyl-CoA and N-Acetyl-Glucosamin (GlcNAc), released by the metabolism of mucus through commensal
+
                        microorganisms [9]. As soon as the probiotic leaves its designated area, the repression of the
+
                         kill switch is abrogated and the CRISPR/Cas3 system activated. The kill-switch therefore, is a
+
                        concept that can be used for a diverse spectrum of therapies by exchanging the drug and/or the conditions.
+
 
                     </p>
 
                     </p>
                </div>
+
                    <figure>
 
+
                <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/5/57/T--Tuebingen--Kill-Switch-desc-transparent.png"
+
                           href="https://2019.igem.org/wiki/images/b/bf/T--Tuebingen--H2O2-triplicates-white.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/5/57/T--Tuebingen--Kill-Switch-desc-transparent.png"
+
                             <img src="https://2019.igem.org/wiki/images/b/bf/T--Tuebingen--H2O2-triplicates-white.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
                                 alt="A generic square placeholder image with rounded corners in a figure."></a>
+
                                 alt="A generic square placeholder"></a>
 +
                        <figcaption style="font-size: small; color: #F4F0DE">Fig. 4: EcN growth in different concentrations
 +
                            of Hydrogen Peroxide, infused after two hours of growth at 37°C, pH7 in LB medium. 100µM Hydrogen
 +
                            Peroxide with slightly inhibited growth. Shown are the means of triplicates for each concentration.</figcaption>
 
                     </figure>
 
                     </figure>
                </div>
+
                    <p>
 
+
                        Lastly, we performed dryfreezing and recovered EcN afterwards under control conditions [3][4][5],
 +
                        showing that dryfreezing within skim milk protects the bacteria from substantial death.
 +
                    </p>
  
            <h2 style="font-family:'Righteous';">E.coli Nissle Characterisation</h2>
+
                    <figure>
            <div class="row">
+
                        <a style="font-size: small"
                <div class="col-12">
+
                          href="https://2019.igem.org/wiki/images/9/90/T--Tuebingen--Dryfreeze-white.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/9/90/T--Tuebingen--Dryfreeze-white.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="A generic square placeholder"></a>
 +
                        <figcaption style="font-size: small; color: #F4F0DE">Fig. 5: EcN growth of cultures previously
 +
                            subjected to a dryfreeze protocol. Shown are the mean values of triplicates of cultures
 +
                            grown at 37°C, pH7 in LB grown for recovery.</figcaption>
 +
                    </figure>
 
                     <p>
 
                     <p>
                         Despite the wide use of E.coli Nissle (EcN) it is not characterised well enough. To enhance our
+
                         Anaerobic conditions were used to characterize EcN growth under the circumstances provided in
                         knowledge of EcN and to provide crucial information to the scientific community as well as future
+
                         the human intestines. Thus, as a control we compared EcN growth in LB medium versus mGAM medium
                         iGEM teams, we investigated EcN’s transcriptome under different stress conditions. Understanding
+
                         under anaerobic conditions, showing that mGAM, a medium designed for anaerobic application,
                         the complete transcriptome, the expressed genes, post-transcriptional modifications,
+
                         is in fact a more suitable medium.  Then, we subjected the bacteria to metformin treatment,
                         single-nucleotide polymorphisms (SNPs) and additional properties of interest is essential for
+
                         since it is one of the most common treatments of diabetes and is known to accumulate to 720 µM
                        understanding genetic causes of adaptations to stress. The gained insight could
+
                         to 7,2 mM within the intestines due to low bioavailability. [6][7].  We showed that EcN growth
                         lead to the development of more stress resistant strains, improving probiotic treatment to a
+
                         is not substantially influenced by 1,3 mM of metformin into mGAM medium. Moreover, we tested for
                         large degree. Hence, we conducted large-scale RNA-Seq experiments for 12 conditions including
+
                         EcN’s resistance against cholic acid, since it is commonly secreted into the ileum. Here, we
                        aerobic and anaerobic environments. The conditions were chosen after a thorough evaluation of
+
                         added 0.25 mM of cholic acid to mGAM medium, considering that the concentration of free bile
                         EcN’s growth under different strengths of the stress conditions. Additionally, we created the
+
                         salts may rise to 0.25 to 1 mM of total bile salts in the Ileum, with cholic acid only being
                         <a href="https://2019.igem.org/Team:Tuebingen/Model">first ever metabolic model</a> of EcN and
+
                         one component [8][9]. Our results suggest that EcN growth is not greatly influenced by cholic acid.
                        made it available to the iGEM and general scientific community.
+
                         Moreover, we modelled <a href="https://2019.igem.org/Team:Tuebingen/Nissle">the interaction of EcN</a>
+
                        with three different bacterial communities -
+
                         cutting-edge research and a novelty in the iGEM competition.
+
 
                     </p>
 
                     </p>
 +
                    <figure>
 +
                        <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/b/b2/T--Tuebingen--anaerobic-all-4x-white.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/b/b2/T--Tuebingen--anaerobic-all-4x-white.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="A generic square placeholder"></a>
 +
                        <figcaption style="font-size: small; color: #F4F0DE">Fig. 6: EcN growth under four anaerobic
 +
                            conditions compared to EcN aerobic growth. Shown are the mean values of four samples
 +
                            inoculated with the same overnight culture. Experiments were conducted at 37°C and pH7.
 +
                            LB aerobic growth as a control. Other samples are LB anaerobic growth, mGAM anaerobic
 +
                            growth, as well as mGAM medium supplemented with either 1.3 mM Metformin or 0.25mM Cholic
 +
                            Acid. Samples for RNA sequencing were taken after 270 minutes for all anaerobic conditions,
 +
                            since the increase of pressure within the flasks indicated a change of metabolism of EcN to
 +
                            fermentation processes. Aerobic LB growth samples were taken at OD600=1.0.</figcaption>
 +
                    </figure>
 +
                    <p>
 +
                        Finally, we tested EcN interaction with other bacteria by adding bacterial supernatant to our
 +
                        medium. The supernatant was sterilized and provided by Dr. Lisa Maier. We chose Bacteroides
 +
                        thetaiotaomicron, Prevotella copri and Ruminococcus gnavus since they are commonly found within
 +
                        the human microbiome [10]. Bifidobacterium adolescentis was chosen due to its probiotic nature
 +
                        and Clostridium difficile supernatant was used, since it is often found in the microbiome of people
 +
                        with chronic inflammation [10][11]. The results suggest that EcN grows under all additions,
 +
                        however was initially inhibited in its growth by the addition of Bacteroides spp., thus we used
 +
                        these samples for RNA-seq.
 +
                    </p>
 +
 +
                    <figure>
 +
                        <a style="font-size: small"
 +
                          href="https://2019.igem.org/wiki/images/7/74/T--Tuebingen--bacterial-SN-white.png"
 +
                          data-effect="mfp-zoom-out"
 +
                          title="Some title">
 +
                            <img src="https://2019.igem.org/wiki/images/7/74/T--Tuebingen--bacterial-SN-white.png"
 +
                                class="figure-img img-fluid rounded"
 +
                                alt="A generic square placeholder"></a>
 +
                        <figcaption style="font-size: small; color: #F4F0DE">Fig. 7: EcN growth in mGAM medium under
 +
                            anaerobic conditions at 37°C, pH 7 supplemented with either 50% supernatant of different
 +
                            species or 50% of water as a control for depleted nutrients. All cultures were inoculated
 +
                            with the same overnight culture of EcN. Bacteroides spp. with strongest change in growth
 +
                            within the first 200 min of the experiment. Shown are mean values of four samples each.
 +
                            Bacteroides samples were taken for RNA sequencing after 225 minutes.</figcaption>
 +
                    </figure>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
  
             <h2 style="font-family:'Righteous'; color:#2ecc71;">Software</h2>
+
             <h2 style="font-family:'Righteous';">RNASeq</h2>
 
+
 
+
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col-12">
 
                 <div class="col-12">
 
                     <p>
 
                     <p>
                         To transport Exendin-4 across the membrane of the enterocytes in the gut, we decided to utilize
+
                         The transcriptome describes the set of whole RNA molecules in a population of cells and is subject
                         cell-penetrating peptides (CPPs) as a carrier. CPPs have already been proven to transport different
+
                        to continuous changes. Understanding the complete transcriptome, the expressed genes, post-transcriptional
                         cargos like insulin, from the gut to the bloodstream [98]. To better understand the mechanism
+
                         modifications, single-nucleotide polymorphisms (SNPs) and additional properties of interest is
                        of action of CPPs and to make an educated decision for choosing the CPP domain in our project
+
                         imperative towards understanding genetic cause, disease and possible treatment strategies.
                        design, we decided to generate a machine learning model to predict the cargo transport efficiency.
+
The inherent complexity of the transcriptome requires precise and scaling analysis techniques. RNA sequencing (RNA-seq),
                    </p>
+
                         also known as whole transcriptome shotgun sequencing (WTSS), is most commonly used for this purpose,
                    <p>
+
                         today. It uses next-generation sequencing (NGS) to detect and quantify RNA in biological samples.
                         CPPs gain more and more attention in the scientific field, with multiple peptides being in clinical
+
The generated RNA-Seq read data is then analyzed according to a sample RNA-Seq work-flow as shown below.
                         trials to deliver drug molecules to target sites in patients [99]. Since they can be used in
+
                        various transport scenarios,  many iGEM teams submitted CPPs to the registry in the past years.
+
                        Therefore, we made our transport effectivity quantification software available to all future
+
                        iGEM teams and the scientific community. To ensure excellent usability, <a href="https://2019.igem.org/Team:Tuebingen/Software">
+
                        we implemented a web</a> GUI that allows multiple input formats.
+
 
                     </p>
 
                     </p>
                </div>
+
                    <figure>
            </div>
+
                <figure>
+
 
                         <a style="font-size: small"
 
                         <a style="font-size: small"
                           href="https://2019.igem.org/wiki/images/2/23/T--Tuebingen--CPP-function-transparent.png"
+
                           href="https://2019.igem.org/wiki/images/7/7f/T--Tuebingen--RNA-Seq-transparent.png"
 
                           data-effect="mfp-zoom-out"
 
                           data-effect="mfp-zoom-out"
 
                           title="Some title">
 
                           title="Some title">
                             <img src="https://2019.igem.org/wiki/images/2/23/T--Tuebingen--CPP-function-transparent.png"
+
                             <img src="https://2019.igem.org/wiki/images/7/7f/T--Tuebingen--RNA-Seq-transparent.png"
 
                                 class="figure-img img-fluid rounded"
 
                                 class="figure-img img-fluid rounded"
 
                                 alt="A generic square placeholder image with rounded corners in a figure."></a>
 
                                 alt="A generic square placeholder image with rounded corners in a figure."></a>
 
                     </figure>
 
                     </figure>
 
            <div class="row">
 
                <div class="col-12">
 
                    <h3 style="font-family:'Righteous'; color:#2ecc71;">Human Practices & Public Outreach</h3>
 
 
                     <p>
 
                     <p>
                         Since our project involves the use of GMOs, which are a constant topic of debate, we realised
+
                         We set ourselves the goal of understanding the transcriptomic changes that E.coli Nissle undergoes
                        that we needed to invest into spreading awareness and especially <a href="https://2019.igem.org/Team:Tuebingen/Public_Engagement">education about GMOs</a>,
+
                         under various stress conditions to gain a deeper insight into its responses. Understanding the
                         synthetic biology and Diabetes.
+
                         stress responses of E.coli Nissle could lead to the development of more stress robust strains,
                        We therefore contacted <a href="https://2019.igem.org/Team:Tuebingen/Experts">several experts</a> and teamed
+
                         which not only our project would benefit from, but also scientists working on probiotic drugs in general.
                         up with a variety of institutions, researchers and also iGEM teams in order to address this.
+
                        Several <a href="https://2019.igem.org/Team:Tuebingen/Collaborations">collaborations</a>, meetups, exchanges
+
                         and talks provided us with valuable information for our project and helped developing it over
+
                        the year. Learn more about our Human Practices under <a href="https://2019.igem.org/Team:Tuebingen/Human_Practices">Human Practices</a> / Overview.
+
 
                     </p>
 
                     </p>
                </div>
 
            </div>
 
 
            <div class="row">
 
                <div class="col-12">
 
                    <h2 style="font-family:'Righteous';">Wetlab Project Plan</h2>
 
 
 
                     <p>
 
                     <p>
                         To conclude, our projects required intensive cloning of multiple regulatory elements. For the parts, we used Biobricks that were sent with the 2019 shipping, Biobrick sequences from the database of iGEM, as well as new sequences, which are unique to our project, like the Exendin-4 fusion construct or the GlcNAc-6-P sensing system. After synthesis, the GOI constructs were amplified and cloned into vectors. These were used to transform competent E. coli cells that are commonly used for cloning applications, as they can be manipulated easily. Here, we can already test whether our GOI construct works and Exendin-4 is secreted in a glucose dependent manner.
+
                         We divided our experimental design into two parts. We not only wanted to investigate the effect
 +
                        of environmental stress on E.coli Nissle under aerobic conditions, but were also specifically
 +
                        interested in anaerobic conditions. Hence, our experimental design looks as follows:
 
                     </p>
 
                     </p>
 
 
                     <p>
 
                     <p>
                         At the same time the Cas3 system was isolated from E. coli K12, and the DNA with regulatory
+
                         The respective temperature, pH values and doses were determined by growth curves, shown above.
                        system was changed in E. coli K12 to our individual sensing mechanisms. The functionality of
+
                         To get the most out of RNA-Seq applied to stress factors, it is important to find the cutoff
                         the kill switch and the different conditions for it can be tested already. If the construct
+
                         values, where E.coli Nissle is put under stress the most, but still survives.
                        shows the desired activity, it can be integrated into the E. coli Nissle 1917 genome.
+
                         Finally, we hoped to combine our GOI with the Cas3 positive E. coli Nissle 1917 and test the
+
                        functionality of our system as a whole. More precisely, we wanted to test if the generated strain  secretes Exendin-4 in the presence of glucose, and if it destructs itself under conditions diverting from the gut.
+
 
                     </p>
 
                     </p>
 
                     <p>
 
                     <p>
                         In the future, we will proceed with experiments on human cell lines. Firstly, the transport of the Exendin-4 through a CaCo-2 cell monolayer will be tested to investigate, whether there will be a drug, which can reach the pancreas. Secondly, we will work with Rat Insulinoma cell line INS-1 cells, to examine whether Exendin-4 will induce an Insulin expression.
+
                         Sequencing and library preparation was conducted on two sites. All aerobic samples were prepared
 +
                        and sequenced at the NGS Competence Center Tübingen (NCCT), whereas all anaerobic samples were
 +
                        prepared and sequenced at the European Molecular Biology Laboratory (EMBL) in Heidelberg.
 +
                        For more details please visit our <a href="https://2019.igem.org/Team:Tuebingen/Notebook" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Notebook","_self");'>Notebook</a>
 +
                        and <a href="https://2019.igem.org/Team:Tuebingen/Attributions" onclick='window.open("https://2019.igem.org/Team:Tuebingen/Attributions","_self");'>Attributions</a>.
 
                     </p>
 
                     </p>
  
 +
                    </div>
 +
                </div>
 +
 +
 +
            <h2 style="font-family:'Righteous';">Data Analysis</h2>
 +
            <div class="row">
 +
                <div class="col-12">
 +
                    <p>Quality Control Differential Expression Analysis
 +
                        Pathway Analysis</p>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
 +
 +
            <h2 style="font-family:'Righteous'; color:#2ecc71;">Metabolic Model</h2>
 +
 +
 +
            <div class="row">
 +
                <div class="col-12">
 +
                    <p>Insert here</p>
 +
                </div>
 +
            </div>
 +
 
         </div>
 
         </div>
  
 
           <div id="glpreferences" class="row">
 
           <div id="glpreferences" class="row">
 
                 <h3 style="font-family:'Righteous'; color: #2ecc71;">References</h3>
 
                 <h3 style="font-family:'Righteous'; color: #2ecc71;">References</h3>
                 <div class="col-12">
+
                 <div class="col-12" style="font-size: x-small; overflow-wrap: break-word;">
 
                     <ol>
 
                     <ol>
                         <li><a href=https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=8D5E18D2A5627102F238B7D2DA7AD2C4?sequence=1> World Health Organization. (2016).
+
                         <li style="color: #F4F0DE"><a href=https://doi.org/10.1093/femsle/fnw212> Ulrich Sonnenborn, Escherichia coli strain Nissle 1917—from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties, FEMS Microbiology Letters, Volume 363, Issue 19, October 2016, fnw212,</a></li>
                            Global Report on Diabetes. Available online; [Accessed 26.03.2019].</a></li>
+
                         <li id="ref_2" style="color: #F4F0DE">Sana Ben Othman and Tomio Yabe. Use of Hydrogen Peroxide and Peroxl Radicals to induce Oxidative Stress in Neuronal Cells. Reviews in Agricultural Science, 3:40-45, 2015. Doi: 10.7831/ras.3.40</li>
                        <li id="ref_2"><a href=https://www.physiology.org/doi/abs/10.1152/physrev.00034.2006> Jens Juul Holst. The Physiology of Glucagon-like Peptide 1. (2007). Physiological Reviews. p.1409-1439.</a></li>
+
                         <li id="ref_3" style="color: #F4F0DE;">P. Capela, T.K.C. Hay, N.P. Shah. Effect of cryoprotectants, prebiotics and microencapsulation on survival of probiotic organisms in yoghurt and freeze-dried yoghurt. Food Research International. Volume 39, Issue 2, 2006, Pages 203-211, ISSN 0963-9969, https://doi.org/10.1016/j.foodres.2005.07.007.</li>
                         <li id="ref_3" style="color: #F4F0DE;">
+
                         <li id="ref_4" style="color: #F4F0DE;">Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014;15(1):29–43. doi:10.1208/s12249-013-0027-1</li>
                            Lim, Gareth E., Brubaker, Patricia L. Glucagon-Like Peptide 1 Secretion by the L-Cell. (2006). 10.2337/db06-S020. Diabetes. p. S70-S77</li>
+
                         <li id="ref_5" style="color: #F4F0DE;"><a href="https://opsdiagnostics.com/applications/lyophilization/ecoli_lyophilization_stability.html">https://opsdiagnostics.com/applications/lyophilization/ecoli_lyophilization_stability.html</a> </li>
                         <li id="ref_4" style="color: #F4F0DE;">Copley, Kathrin & McCowen, Kevin & Hiles, Richard & L Nielsen, Loretta & Young, Andrew & Parkes, David. (2006). Investigation of Exenatide Elimination and Its In Vivo and In Vitro Degradation. Current drug metabolism. 7. 367-74. 10.2174/138920006776873490.</li>
+
                         <li id="ref_6" style="color: #F4F0DE;"><a href="https://doi.org/10.1007/s00125-008-1053-5"></a>Bailey, C. J, Wilcock, C, Scarpello, J. H. B. Metformin and the intestine. Diabetologia. 2008. Volume 51, Issue 8, Pages 1552, ISSN 1432-0428, Doi: 10.1007/s00125-008-1053-5,</li>
                         <li id="ref_5" style="color: #F4F0DE;">Duan F, Curtis KL, March JC. Secretion of insulinotropic proteins by commensal bacteria: rewiring the gut to treat diabetes. Appl Environ Microbiol. (2008);74(23):7437–7438. doi:10.1128/AEM.01019-08</li>
+
                         <li id="ref_7" style="color: #F4F0DE;">High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome. Paleari, LauraBurhenne, JürgenFoersch, SebastianParodi, AndreaGnant, MichaelScherer, DominiqueUlrich, Cornelia M.Stabuc, BorutPuntoni, MatteoCoccia, GianniPetrera, MarilenaHaefeli, Walter-EmilDeCensi, Andrea et al. Gastroenterology, Volume 154, Issue 5, 1543 - 1545</li>
                        <li id="ref_6" style="color: #F4F0DE;">Duan FF, Liu JH, March JC. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes. (2015);64(5):1794–1803. doi:10.2337/db14-0635</li>
+
                         <li id="ref_8" style="color: #F4F0DE;">Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J Gastroenterol. 2008;14(37):5630–5640. doi:10.3748/wjg.14.5630</li>
                         <li id="ref_7" style="color: #F4F0DE;"><a href="http://2017.igem.org/Team:AQA_Unesp">iGEM Team AQA_Unesp</a></li>
+
                         <li id="ref_9" style="color: #F4F0DE;">Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. T. C. NORTHFIELD AND I. McCOLL. Gut, 1973, 14, 513-518</li>
                        <li id="ref_8"><a href="http://2012.igem.org/Team:NTU-Taida/Project/Circuit">Team NTU-Taida</a></li>
+
                         <li id="ref_10" style="color: #F4F0DE;">Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050. Published 2015 Oct 6. doi:10.3389/fmicb.2015.01050</li>
                         <li id="ref_9" style="color: #F4F0DE;">Sicard JF, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front Cell Infect Microbiol. (2017);7:387. Published 2017 Sep 5. doi:10.3389/fcimb.2017.00387</li>
+
                         <li id="ref_11" style="color: #F4F0DE;">Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. Published 2016 Apr 27. doi:10.1186/s13073-016-0307-y</li>
                        <li id="ref_10" style="color: #F4F0DE;">Barnhart MM, Lynem J, Chapman MR. GlcNAc-6P levels modulate the expression of Curli fibers by Escherichia coli. J Bacteriol. (2006);188(14):5212–5219. doi:10.1128/JB.00234-06</li>
+
                         <li id="ref_11" style="color: #F4F0DE;">Konopka JB. N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica (Cairo). (2012);2012:489208. doi:10.6064/2012/489208</li>
+
                         <li id="ref_12"><a href="https://www.uniprot.org/uniprot/P0A8V6">uniprot</a> accessed: 19 Jun 2019</li>
+
                        <li id="ref_13" style="color: #F4F0DE;">Feng Y, Cronan JE. Crosstalk of Escherichia coli FadR with global regulators in expression of fatty acid transport genes. PLoS One. (2012);7(9):e46275. doi:10.1371/journal.pone.0046275</li>
+
                         <li id="ref_14" style="color: #F4F0DE;">Federle MJ. Autoinducer-2-based chemical communication in bacteria: complexities of interspecies signaling. Contrib Microbiol. (2009);16:18–32. doi:10.1159/000219371</li>
+
                         <li id="ref_15" style="color: #F4F0DE;">Griffiths AJF, Miller JH, Suzuki DT, et al. An Introduction to Genetic Analysis. 7th edition. New York: W. H. Freeman; (2000). Catabolite repression of the lac operon: positive control. Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK22065/"></a></li>
+
                        <li id="ref_16" style="color: #F4F0DE;">IDF (International Diabetes Federation. IDF Diabetes Atlas. (2017). Eighth Edition. Available from: <a href="https://diabetesatlas.org/resources/2017-atlas.html"></a></li>
+
                         <li id="ref_17"><a href="https://www.experimenta.science/">Experimenta</a></li>
+
                        <li id="ref_18" style="color: #F4F0DE;"><a href="https://www.un.org/sustainabledevelopment/">UN-SDG</a></li>
+
                        <li id="ref_19" style="color: #F4F0DE;"><a href="https://igem-tuebingen.com/human_practices">Tuebingen:Human_Practices</a></li>
+
                        <li id="ref_20" style="color: #F4F0DE;"><a href="https://2019.igem.org/Team:Costa_Rica/SDG-Challenge">Team CostaRica SDG</a></li>
+
                        <li id="ref_21" style="color: #F4F0DE;"><a href="https://forms.gle/xtoeMHuAMpDHeaCc9">Team Taipei video conference</a></li>
+
                        <li id="ref_22" style="color: #F4F0DE;"><a href="https://www.jenabioscience.com/probes-epigenetics/cell-labeling/protein-and-nucleic-acid-internalization/single-cell-penetrating-peptides-cpps/cpp-p01-penetratin">Jenabioscience</a></li>
+
 
                     </ol>
 
                     </ol>
 
                 </div>
 
                 </div>

Revision as of 19:54, 16 October 2019

GLP.exe

Nissle

Introduction

Escherichia coli Nissle 1917 (EcN) is probably the most intensively investigated bacterial strain today[1]. Despite the fact that the EcN strain is widely used as a probiotic, a lot of questions remain. That is why we decided to dive deep into the characterization of EcN. Our goal was to find out more about EcN itself and to provide crucial information in order to include EcN as platform organism for other iGEM Teams and researchers.

Growth Curves

The first step in the characterization of a bacterium are growth curves on different media and under different conditions. We chose to perform half of our experiments under aerobic and the other half under anaerobic conditions. Under aerobic conditions, as a control we let EcN grow in LB medium at 37°C and pH7. We changed the temperature to 25°C, 8°C, 4°C and 0°C, showing that EcN growth is inhibited at 8°C, the temperature often used for cold shock.

A generic square placeholder
Fig. 1: EcN growth in LB medium at pH7. All cultures were inoculated with an overnight culture and grown for 120 minutes at 37°C. Next, temperature was changed to 0°C, 4°C, 8°C and 25°C, while one control was kept at 37°C. Shown are mean values of triplicates.

Moreover, we evaluated the growth in the pH range from pH6 to pH1, since in our application EcN will have to pass the acidity of the stomach. Here, at pH4 we discovered an interesting recovery of EcN growth after three hours.

A generic square placeholder
Fig. 2: EcN growth curve in LB at 37°C under different pH levels. Until 120min all cultures inoculated from one overnight culture grew at pH7. Then, media was changed to the respective pH and cultures were grown for 3 hours. pH5 and pH6 grew as usual, pH1,2,3 did not grow at all, while pH4 started to grow after 3 hours. Thus, media was changed again after 3 hours to pH7. pH6 and pH5 grew as usual, pH1,2,3 did not recover. Cultures grown in pH4 recovered and grew as usual. Shown are values of one culture for each pH.
A generic square placeholder
Fig. 3: EcN growth in LB at 37°C with pH changed from pH7 to pH4 after two hours of growth. After 150 minutes within pH4, EcN started to grow comparable to pH7 cultures. Shown are the three cultures inoculated from the same overnight culture of EcN.

To look into inflammatory stress, we subjected EcN to up to 100µM hydrogen peroxide [2] and showed that the growth is not substantially influenced by it.

A generic square placeholder
Fig. 4: EcN growth in different concentrations of Hydrogen Peroxide, infused after two hours of growth at 37°C, pH7 in LB medium. 100µM Hydrogen Peroxide with slightly inhibited growth. Shown are the means of triplicates for each concentration.

Lastly, we performed dryfreezing and recovered EcN afterwards under control conditions [3][4][5], showing that dryfreezing within skim milk protects the bacteria from substantial death.

A generic square placeholder
Fig. 5: EcN growth of cultures previously subjected to a dryfreeze protocol. Shown are the mean values of triplicates of cultures grown at 37°C, pH7 in LB grown for recovery.

Anaerobic conditions were used to characterize EcN growth under the circumstances provided in the human intestines. Thus, as a control we compared EcN growth in LB medium versus mGAM medium under anaerobic conditions, showing that mGAM, a medium designed for anaerobic application, is in fact a more suitable medium. Then, we subjected the bacteria to metformin treatment, since it is one of the most common treatments of diabetes and is known to accumulate to 720 µM to 7,2 mM within the intestines due to low bioavailability. [6][7]. We showed that EcN growth is not substantially influenced by 1,3 mM of metformin into mGAM medium. Moreover, we tested for EcN’s resistance against cholic acid, since it is commonly secreted into the ileum. Here, we added 0.25 mM of cholic acid to mGAM medium, considering that the concentration of free bile salts may rise to 0.25 to 1 mM of total bile salts in the Ileum, with cholic acid only being one component [8][9]. Our results suggest that EcN growth is not greatly influenced by cholic acid.

A generic square placeholder
Fig. 6: EcN growth under four anaerobic conditions compared to EcN aerobic growth. Shown are the mean values of four samples inoculated with the same overnight culture. Experiments were conducted at 37°C and pH7. LB aerobic growth as a control. Other samples are LB anaerobic growth, mGAM anaerobic growth, as well as mGAM medium supplemented with either 1.3 mM Metformin or 0.25mM Cholic Acid. Samples for RNA sequencing were taken after 270 minutes for all anaerobic conditions, since the increase of pressure within the flasks indicated a change of metabolism of EcN to fermentation processes. Aerobic LB growth samples were taken at OD600=1.0.

Finally, we tested EcN interaction with other bacteria by adding bacterial supernatant to our medium. The supernatant was sterilized and provided by Dr. Lisa Maier. We chose Bacteroides thetaiotaomicron, Prevotella copri and Ruminococcus gnavus since they are commonly found within the human microbiome [10]. Bifidobacterium adolescentis was chosen due to its probiotic nature and Clostridium difficile supernatant was used, since it is often found in the microbiome of people with chronic inflammation [10][11]. The results suggest that EcN grows under all additions, however was initially inhibited in its growth by the addition of Bacteroides spp., thus we used these samples for RNA-seq.

A generic square placeholder
Fig. 7: EcN growth in mGAM medium under anaerobic conditions at 37°C, pH 7 supplemented with either 50% supernatant of different species or 50% of water as a control for depleted nutrients. All cultures were inoculated with the same overnight culture of EcN. Bacteroides spp. with strongest change in growth within the first 200 min of the experiment. Shown are mean values of four samples each. Bacteroides samples were taken for RNA sequencing after 225 minutes.

RNASeq

The transcriptome describes the set of whole RNA molecules in a population of cells and is subject to continuous changes. Understanding the complete transcriptome, the expressed genes, post-transcriptional modifications, single-nucleotide polymorphisms (SNPs) and additional properties of interest is imperative towards understanding genetic cause, disease and possible treatment strategies. The inherent complexity of the transcriptome requires precise and scaling analysis techniques. RNA sequencing (RNA-seq), also known as whole transcriptome shotgun sequencing (WTSS), is most commonly used for this purpose, today. It uses next-generation sequencing (NGS) to detect and quantify RNA in biological samples. The generated RNA-Seq read data is then analyzed according to a sample RNA-Seq work-flow as shown below.

A generic square placeholder image with rounded corners in a figure.

We set ourselves the goal of understanding the transcriptomic changes that E.coli Nissle undergoes under various stress conditions to gain a deeper insight into its responses. Understanding the stress responses of E.coli Nissle could lead to the development of more stress robust strains, which not only our project would benefit from, but also scientists working on probiotic drugs in general.

We divided our experimental design into two parts. We not only wanted to investigate the effect of environmental stress on E.coli Nissle under aerobic conditions, but were also specifically interested in anaerobic conditions. Hence, our experimental design looks as follows:

The respective temperature, pH values and doses were determined by growth curves, shown above. To get the most out of RNA-Seq applied to stress factors, it is important to find the cutoff values, where E.coli Nissle is put under stress the most, but still survives.

Sequencing and library preparation was conducted on two sites. All aerobic samples were prepared and sequenced at the NGS Competence Center Tübingen (NCCT), whereas all anaerobic samples were prepared and sequenced at the European Molecular Biology Laboratory (EMBL) in Heidelberg. For more details please visit our Notebook and Attributions.

Data Analysis

Quality Control Differential Expression Analysis Pathway Analysis

Metabolic Model

Insert here

References

  1. Ulrich Sonnenborn, Escherichia coli strain Nissle 1917—from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties, FEMS Microbiology Letters, Volume 363, Issue 19, October 2016, fnw212,
  2. Sana Ben Othman and Tomio Yabe. Use of Hydrogen Peroxide and Peroxl Radicals to induce Oxidative Stress in Neuronal Cells. Reviews in Agricultural Science, 3:40-45, 2015. Doi: 10.7831/ras.3.40
  3. P. Capela, T.K.C. Hay, N.P. Shah. Effect of cryoprotectants, prebiotics and microencapsulation on survival of probiotic organisms in yoghurt and freeze-dried yoghurt. Food Research International. Volume 39, Issue 2, 2006, Pages 203-211, ISSN 0963-9969, https://doi.org/10.1016/j.foodres.2005.07.007.
  4. Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014;15(1):29–43. doi:10.1208/s12249-013-0027-1
  5. https://opsdiagnostics.com/applications/lyophilization/ecoli_lyophilization_stability.html
  6. Bailey, C. J, Wilcock, C, Scarpello, J. H. B. Metformin and the intestine. Diabetologia. 2008. Volume 51, Issue 8, Pages 1552, ISSN 1432-0428, Doi: 10.1007/s00125-008-1053-5,
  7. High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome. Paleari, LauraBurhenne, JürgenFoersch, SebastianParodi, AndreaGnant, MichaelScherer, DominiqueUlrich, Cornelia M.Stabuc, BorutPuntoni, MatteoCoccia, GianniPetrera, MarilenaHaefeli, Walter-EmilDeCensi, Andrea et al. Gastroenterology, Volume 154, Issue 5, 1543 - 1545
  8. Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J Gastroenterol. 2008;14(37):5630–5640. doi:10.3748/wjg.14.5630
  9. Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. T. C. NORTHFIELD AND I. McCOLL. Gut, 1973, 14, 513-518
  10. Belizário JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050. Published 2015 Oct 6. doi:10.3389/fmicb.2015.01050
  11. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. Published 2016 Apr 27. doi:10.1186/s13073-016-0307-y